Extremely High Cost Drugs

 July 29th, 2017
bio, ideas
Let's say a company discovers a new drug that's far more effective than the current standard of care. [1] They get it through clinical trials, it still looks amazing, then they start selling it. But they set the price incredibly high.

My understanding is that insurance companies in the US are not allowed to refuse to cover a drug on the basis of cost, and they're not allowed to have limits on what they'll pay for someone's care. So what happens? Why aren't new drugs much much more expensive than they currently are?

Update 2017-08-01: From the comments it sounds like it's coinsurance (percentage co-pays) on high cost drugs that keeps this in check.


[1] If it's only a little bit better the insurance company could argue "sure it looks good in your N=500 tests, but we don't think this effect will hold up" or something. But if it's plainly much better then they wouldn't be successful with this I think?

Comment via: google plus, facebook, substack

Recent posts on blogs I like:

The benchmarkpocalypse

There's been a lot of talk about the vulnpocalypse, to which I don't have much to add because I'm not a security person, but I haven't seen much discussion on the closely related (and to be fair, less serious, issue), the benchmarkpocalyps…

via Posts on August 17, 2026

You can't join the secret inner circle of cool effective altruists

I, and a lot of other people I know, seem to believe something like this:

via Thing of Things August 11, 2026

Microfictions 2

A few more microfictions, still no LLMs.

via Evan Fields August 7, 2026

more     (via openring)